References of "REGINSTER, Jean-Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailManagement of osteoporosis after multi-risks assessment in French postmenopausal women
Tancredi, Annalisa ULiege; Bosio-Le Goux, B.; Augendre-Ferrante, B. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 108

Detailed reference viewed: 9 (0 ULiège)
Full Text
Peer Reviewed
See detailPostmenopausal women initiating an antiosteoporotic treatment reported high prevalence of risk factors for cardiovascular diseases
Tancredi, Annalisa ULiege; Bosio-Le Goux, B.; Augendre-Ferrante, B. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 107

Detailed reference viewed: 8 (0 ULiège)
Full Text
Peer Reviewed
See detailBody composition, bone mineral density and Baecke physical activity scores in women aged 25 to 49 years
Gourlay, M. L.; Richy, Florent; Garrett, J. M. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 106

Detailed reference viewed: 10 (0 ULiège)
Full Text
Peer Reviewed
See detailD-hormone analog alfacalcidol: its role in postmenopausal osteoporosis and rheumatoid arthritis management
Richy, Florent; DEROISY, Rita ULiege; LECART, Marie-Paule ULiege et al

in Osteoporosis International (2005, March), 16(Suppl.3), 105-106

Detailed reference viewed: 12 (1 ULiège)
Full Text
Peer Reviewed
See detailPatients prefer calcium+vitamin D3 chewable tablets (Steovit D3) above calcium+vitamin D3 effervescent powder (Cacit D3)
Kaufman, Jean-Marc; DEROISY, Rita ULiege; Gangji, V. et al

in Osteoporosis International (2005, March), 16(Suppl.3),

Detailed reference viewed: 147 (0 ULiège)
Full Text
Peer Reviewed
See detailMonthly oral ibandronate is at least as effective as daily oral ibandronate: 1-year results from MOBILE
Reginster, Jean-Yves ULiege; Cooper, Cyrus; Miller, P. D. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 81-82

Detailed reference viewed: 14 (0 ULiège)
Full Text
Peer Reviewed
See detailVitamin D inadequacy: global prevalence and skeletal implications
Reginster, Jean-Yves ULiege; Richy, Florent; Rabenda, Véronique ULiege et al

in Osteoporosis International (2005, March), 16(Suppl.3), 64

Detailed reference viewed: 12 (4 ULiège)
Full Text
Peer Reviewed
See detailStrontium ranelate inhibits urinary excretion of CTX-II, a marker of cartilage degradation, in postmenopausal women
Alexandersen, P.; Tanko, L. B.; Bagger, Y. Z. et al

in Osteoporosis International (2005, March), 16(suppl.3), 60

Detailed reference viewed: 13 (2 ULiège)
Full Text
Peer Reviewed
See detailHealth-related quality of life as a predictor of direct costs in osteoarthritis
Ethgen, Olivier ULiege; Richy, Florent; Cools, P. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 59

Detailed reference viewed: 9 (1 ULiège)
Full Text
Peer Reviewed
See detailstrontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture
Reginster, Jean-Yves ULiege; Rizzoli, René; Balogh, A. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 53

Detailed reference viewed: 9 (2 ULiège)
Full Text
Peer Reviewed
See detailPreference and acceptability of calcium plus vitamin D3 formulations
Ljunggren, Ö; Andonopoulos, A. P.; Lehtonen-Veromaa, M. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 52

Detailed reference viewed: 31 (1 ULiège)
Full Text
Peer Reviewed
See detailThe management of postmenopausal osteoporosis: a position paper of the world health origination collaborating center on public health aspects of rheumatic diseases
Delmas, Pierre D; Khaltaev, N.; Arriagada, M. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 47

Detailed reference viewed: 15 (0 ULiège)
Full Text
Peer Reviewed
See detailStrontium Ranelate: A New Treatment for Postmenopausal Osteoporosis with a Dual Mode of Action
Reginster, Jean-Yves ULiege; Sarlet, Nathalie ULiege; LEJEUNE, Eric ULiege et al

in Current Osteoporosis Reports (2005), 3(1), 30-4

In vitro, strontium ranelate increases collagen and noncollagen protein synthesis by mature osteoblast-enriched cells. Its effects on bone formation were confirmed as the drug enhanced preosteoblastic ... [more ▼]

In vitro, strontium ranelate increases collagen and noncollagen protein synthesis by mature osteoblast-enriched cells. Its effects on bone formation were confirmed as the drug enhanced preosteoblastic cell replication. In the isolated osteoclast, preincubation of bone slices with strontium ranelate-induced dose-dependent inhibition of the bone-resorbing activity of treated rat osteoclast. Strontium ranelate dose-dependently inhibited preosteoclast differentiation. Its effect in postmenopausal women with established osteoporosis was assessed during an international, prospective, double-blind, randomized, placebo-controlled phase 3 program comparing strontium ranelate 2 g daily with placebo. The 3-year analysis of the phase 3 study, Spinal Osteoporosis Therapeutic Intervention, evaluating the effect of strontium ranelate 2 g/day on vertebral fracture rates, revealed a significant 41% reduction in the relative risk of patients experiencing new vertebral fracture with strontium ranelate over 3 years. A second phase 3 study showed a significant reduction in the relative risk of experiencing a nonvertebral fracture in the group treated with strontium ranelate over 3 years. These results show that strontium ranelate is a new, effective, and safe treatment for vertebral and hip osteoporosis, with a unique mode of action, increasing bone formation and decreasing bone resorption leading to a rebalance of bone turnover in favor of bone formation. [less ▲]

Detailed reference viewed: 48 (4 ULiège)
Full Text
Peer Reviewed
See detailAnalysis of the discriminant ability of shorter versions of the French ADAM questionnaire
Tancredi, Annalisa ULiege; Legros, Jean-Jacques ULiege; Pire, George et al

in Osteoporosis International (2005, March), 16(Suppl.3), 39

Detailed reference viewed: 16 (4 ULiège)
Full Text
Peer Reviewed
See detailShort-term daily administration of 1500 mg glucosamine contributes to symptomatic improvement of osteoarthritis
Reginster, Jean-Yves ULiege; Imschoot, J.; Ghys, A.

in Osteoporosis International (2005, March), 16(Suppl.3), 33

Detailed reference viewed: 7 (0 ULiège)
Full Text
Peer Reviewed
See detailPhysical functionning is the most severely affected health-related quality of life dimension during the aging process
Ethgen, Olivier ULiege; Gosset, Christiane ULiege; De Maeseneer, J. et al

in Osteoporosis International (2005, March), 16(Suppl.3), 25-26

Detailed reference viewed: 7 (2 ULiège)
Full Text
Peer Reviewed
See detailAge- and sex-stratified prevalence of physical disabilities and handicap in the general population
Ethgen, Olivier ULiege; GILLAIN, Daniel ULiege; Gillet, Pierre ULiege et al

in Osteoporosis International (2005, March), 16(Suppl.3), 25

Detailed reference viewed: 28 (4 ULiège)